Skip to main content
. 2018 Nov 9;41(2):753–764. doi: 10.3892/or.2018.6859

Figure 3.

Figure 3.

TROP2 enhances proliferation and viability of glioblastoma cells. (A) Glioblastoma cell proliferation was measured by MTT assay. (B) BrdU incorporation assay was performed to examine the percentage of cells in S-phase. (C) Flow cytometric analysis of cell cycle distribution in U-87 MG and LN-229 cell lines. (D) Representative images of Tunnel assay for U-87 MG and LN-229 cell lines. All data are shown as the means ± SD; *P<0.05, **P<0.01, ***P<0.001. All P-values are based on control vs. treatment group. TROP2, trophoblast cell surface antigen 2.